Post by: Charley Turton Today the Ockenden report into failings in maternity care at the Shrewsbury and Telford Hospital NHS Trust has been published. Vanessa Cashman of 12KBW’s clinical negligence team will bring you a blog post offering analysis of the report in the coming weeks. For those of you who cannot wait that long, … Continue reading Publication of the final Ockenden Report into Shrewsbury and Telford Hospital NHS Trust
In this post, Cressida Mawdesley-Thomas discusses issues of women's rights in healthcare, following the fourth annual conference focused on Women’s Rights in Healthcare, hosted by Leigh Day.
In this blog post, Megan Griffiths considers the Court of Appeal’s recent judgment which overturned the High Court’s issue of a declaration and guidance on the ability of minors to consent to puberty-blocking treatment.
In this post, Vanessa Cashman discusses this recent criminal prosecution regarding the failings in maternity care from East Kent Hospitals University NHS Foundation Trust. It is a landmark case, being the first time that the CQC has prosecuted an NHS Trust over failings in clinical care.
In this post, Megan Griffiths looks at the recent case of Brennan and others v (1) City of Bradford Metropolitan District Council (2) Leeds Teaching Hospitals NHS Trust 1 WLUK 429, a very sad case concerning the decomposition of a woman's body in a hospital mortuary.
Charley Turton begins 2021 with a look ahead to the Essure sterilisation implant litigation, including in particular how it may be impacted by the damning Cumberlege review. What is Essure? Essure, a permanent, non-surgical birth control implant was approved by NICE and first marketed in the UK in 2009. A small coil made from polyester … Continue reading Essure sterilisation implant litigation: Product liability and clinical negligence post-Cumberlege
In the first post of the second instalment of this two-part series looking at COVID-19 vaccinations, Elizabeth Boulden and Cressida Mawdesley-Thomas consider no-fault compensation under the Vaccine Damage Payment scheme. This article was first published as a News Analysis article on Lexis®PSL.
The Medicines and Healthcare Regulatory Agency (“MHRA”) has given Pfizer-BioNTech’s COVID-19 mRNA Vaccine BNT162b2 temporary authorisation under regulation 174 of the Human Medicines Regulations 2012, which enables temporary authorisation to be granted in response to situations such as pandemics. In this blog, which is the first of a two-part series, Cressida Mawdesley-Thomas considers when there could be civil liability for an unlicensed vaccine. It also considers the conditions imposed by the MHRA for the granting of the temporary authorisation to Pfizer-BioNTech’s COVID-19 vaccine.
Reflections on the Cumberlege Committee Report from a Clinical Negligence Perspective by Henry Charles and Vanessa Cashman
In this article, Isaac Hogarth discusses the issue of the standard of care to be applied to redeployed doctors in a Covid-19 setting. He suggests that legislation would be required to lay down any proposed modifications to the standard of care.